Print Page   |   Sign In   |   Join!
News & Press
Filter news by category:

PSHP Newsletters

Student Submissions
Friday, October 20, 2017   (0 Comments - view/add)
A Student’s Perspective on ASHP Policy Week »
A Student’s Perspective on ASHP Policy Week Brittany Tschaen Pharm.D. Candidate 2018 Jefferson College of...
Tuesday, September 19, 2017   (0 Comments - view/add)
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hype »
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hyperthyroidism in chronic...
Tuesday, September 19, 2017
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype wi »
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype with severe asthma...
Tuesday, September 19, 2017
FDA New Drug Approval: VoseviTM for Hepatitis C therapy in treatment-experienced adults »
FDA New Drug Approval: Vosevi TM for Hepatitis C therapy in treatment-experienced adults Christine Starrs, P...
Tuesday, August 22, 2017
Transitions in a Student Run Clinic »
Student Submission -  Transitions in a Student Run Clinic Bailey Colvin, Doctor of Pharmacy Candidate 2018 Nico...
Monday, July 24, 2017
Historical Impacts of Generic Drug Regulation »
Student Submission - Historical Impacts of Generic Drug Regulation By: Stephanie Liu, PharmD Candidate 2017 Precepto...
Friday, June 30, 2017
Class 1 Drugs, Repurposed Rather Than New »
Student Submission: Class 1 Drugs, Repurposed Rather Than New Jose B. Fernandez Jr., PharmD Class of 2019 Roger Ar...
Thursday, May 18, 2017
Drug review: Descovy »
Student Submission: Drug review: Descovy Christine A. Dimaculangan is a 6th year pharmacy student at the Philadel...
Thursday, April 27, 2017
Bridion®: The First Selective Relaxant Binding Agent for Reversal of Neuromuscular Blockade »
Student Submission: Bridion®: The First Selective Relaxant Binding Agent for Reversal of Neuromuscular Blockade Author:...
Thursday, March 30, 2017
Call for Student Submissions: Guidelines for Submitting your Article to the PSHP Newsletter! »
PSHP Newsletter Article Submission Guidelines How would you like to… Polish your writing skills for f...
Friday, February 24, 2017   (0 Comments - view/add)
The New Hospital-Acquired and Ventilator-Associated Pneumonia Guidelines: A Review of Notable Change »
Jordan Gabrielsen, PharmD Candidate 2018 Preceptor: Raymond Lamore, PharmD, BCPS  The Infectious Disease Soci...
Tuesday, January 31, 2017
Student Submission: Daclizumab – A New Option for Relapsing Multiple Sclerosis »
Anna Krupa, PharmD Candidate 2017 Carol Ly, PharmD Candidate 2018 Jennifer Andres, PharmD, BCPS – Faculty Advisor...
Friday, December 23, 2016   (0 Comments - view/add)
Different Perspectives of American Society of Health-System Pharmacists (ASHP) Mid-Year: A Closer Lo »
Different Perspectives of American Society of Health-System Pharmacists (ASHP) Mid-Year: A Closer Look from P3 to Resident...
Friday, December 2, 2016   (0 Comments - view/add)
How pharmacy students across PA came together to promote PAI »
By: Jenna L. Fancher, M.A. PharmD Candidate 2017 Background       &nb...
Tuesday, November 1, 2016   (0 Comments - view/add)
Talimogene laherparepvec (T-VEC): The first oncolytic virus in the treatment of unresectable melano »
Author: Chris Dorian, PCP PharmD Class of 2019 Faculty Advisor: Nicole Schroeder PharmD,BCPS,BCCCP, Assistant Prof....
Friday, September 30, 2016   (1 Comment - view/add)
Empliciti »
Marijanel Villamayor Alilio, PharmD Candidate 2018 Thao K. Huynh, PharmD, BCOP University of Pittsburgh School of...
Friday, September 2, 2016   (0 Comments - view/add)
ZepatierTM: A New Alternative Oral Treatment for Hepatitis C Virus »
Elizabeth Bracco, PharmD Candidate 2017 Amanda Gerberich, PharmD Candidate 2017 Jaclyn Werkheiser, PharmD Candidat...
Monday, August 1, 2016   (0 Comments - view/add)
Round 2: The Second Match Phase and You »
Round 2: The Second Phase Match and You by Forrest N. Ridgway, PharmD As many of you may now know, the 2016 America...
Tuesday, July 26, 2016   (0 Comments - view/add)
The Impact of Pharmacists on Transitions of Care »
Olivia Stanton-Ameisen, PharmD Candidate 2017 Vilinny Puth, PharmD Candidate 2018 Jennifer Andres, PharmD, BC...
Monday, May 16, 2016   (0 Comments - view/add)
Naloxone: A Lifesaving Antidote in the Epidemic of Opioid Substance »
Jennifer Nguyen, PharmD Candidate 2017 Jasica Truong, PharmD Candidate 2018 Jennifer Andres, PharmD, BCPS Temple Un...
Monday, April 18, 2016   (0 Comments - view/add)
Novel Combination Drug Takes on Heart Failure »
Novel Combination Drug Takes On Heart Failure   Joyce Gambrah, PharmD Candidate 2017 Stacy Pasciolla, Pharm...
Wednesday, April 6, 2016   (0 Comments - view/add)
Temple University School of Pharmacy Flash Mob for Medication Awareness »
March 18, 2016 The Temple University School of Pharmacy is full of smart students, but did you know they can also dance...
Friday, March 25, 2016   (0 Comments - view/add)
SSHP/TUSPAA Mentor Night a Success! »
Peter Nikolos & Jola Salavaci, Pharm.D. Candidates 2017  On Thursday, March 10th, 2016, the Temple Universi...
Tuesday, February 23, 2016   (0 Comments - view/add)
Tagrisso »
Tagrisso ® : The First Agent Approved for the Treatment of Metastatic Epidermal Growth Factor Receptor T790M Mutation-Po...
Tuesday, February 23, 2016   (0 Comments - view/add)
Veltassa; Worth the 50-Year Wait? »
Veltassa TM ; Worth the 50-Year Wait? Tenielle Watkins, PharmD Candidate 2017 Oxana Placinta, PharmD Candidat...
Thursday, January 21, 2016   (0 Comments - view/add)
ASHP Midyear Clinical Meeting 2015 – A Student Perspective »
ASHP Midyear Clinical Meeting 2015 – A Student Perspective Brett Healy, Pharm.D. Candidate 2016 John Marasigan, Pharm....
Thursday, January 21, 2016   (0 Comments - view/add)
An Overview of PCSK9 Inhibitors »
Oludamilola Olugbile PhamD Candidate 2016 Jefferson College of Pharmacy   Donna Peterson PharmD C...
Monday, December 7, 2015   (0 Comments - view/add)
Praxbind®: The First Specific Reversal Agent for the Oral Anticoagulant, Pradaxa® »
Praxbind ® : The First Specific Reversal Agent for the Oral Anticoagulant, Pradax a ®   Taylor Gibbs, P...
Thursday, November 12, 2015   (0 Comments - view/add)
PSHP Student Submission - The Daraprim Controversy: Facts and Media Frenzy »
The Daraprim Controversy: Facts and Media Frenzy Sophie Hien Le, PharmD candidate 2017 Paris Rezai, PharmD cand...
Thursday, October 22, 2015   (0 Comments - view/add)
Student Submission: Savaysa®: A New Anticoagulant for the Treatment of Nonvalvular Atrial Fibrillati »
Savaysa®: A New Anticoagulant for the Treatment of Nonvalvular Atrial Fibrillation   Christine Hancock, Ph...
Thursday, September 17, 2015   (0 Comments - view/add)
Entyvio®: A new option for patients with inflammatory bowel disease »
Entyvio®: A new option for patients with inflammatory bowel disease Amanda Gerberich, PharmD Candidate 2017 Miche...
Wednesday, July 15, 2015
AfrezzaⓇ: Inhaled Rapid-Acting Insulin for the Treatment of Diabetes Mellitus in Adults »
Afrezza Ⓡ : Inhaled Rapid-Acting Insulin for the Treatment of Diabetes Mellitus in Adults Kimberly Pough, PharmD...

more Calendar

11/14/2017
BuxMont Night with Industry and Dinner Meeting

Membership Management Software Powered by YourMembership  ::  Legal